Calamos Advisors
PRVA icon

Calamos Advisors’s Privia Health PRVA Stock Holding History

Calamos Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23,084
Closed -$637K – 1046
2023
Q1 		$637K Buy
23,084
+8,434
+58% +$223K ﹤0.01% 837
2022
Q4 		$333K Sell
14,650
-130,306
-90% -$3.63M ﹤0.01% 924
2022
Q3 		$4.94M Sell
144,956
-71,429
-33% -$2.64M 0.02% 695
2022
Q2 		$6.3M Buy
216,385
+121,249
+127% +$3.08M 0.03% 632
2022
Q1 		$2.54M Buy
+95,136
New +$2.25M 0.01% 870
2021
Q3 		– Sell
-75,350
Closed -$3.34M – 1036
2021
Q2 		$3.34M Buy
+75,350
New +$2.78M 0.02% 641

Other funds holding PRVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Calamos Advisors's PRVA Position: Q2 2023 in Review

Calamos Advisors sold out of Privia Health (PRVA) in Q2 2023, closing a stake of 23,084 shares — an estimated $637K sold.

Calamos Advisors first reported a position in PRVA in Q2 2021 and held it in 6 quarters. The position peaked at $6.3M in Q2 2022. 234 funds tracked by Wall St. Rank hold PRVA as of Q2 2023.

  • Calamos Advisors reported no remaining Privia Health position as of Q2 2023 after selling out during the quarter.
  • Calamos Advisors sold 23,084 Privia Health shares in Q2 2023, an estimated $637K.
  • Calamos Advisors first reported a position in Privia Health in Q2 2021 and held it in 6 quarters.
  • Calamos Advisors's Privia Health position peaked at $6.3M in Q2 2022.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q2 2023.

Based on Calamos Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.